Christopher J R Paszty

Title: Innovations of Christopher J R Paszty

Introduction

Christopher J R Paszty is a notable inventor based in Ventura, California. He holds a total of six patents, showcasing his contributions to the field of biotechnology. His work primarily focuses on developing innovative binding agents and polypeptides that have significant implications for medical treatments.

Latest Patents

Among his latest patents, one invention relates to bispecific binding agents. This invention involves bispecific anti-sclerostin/anti-DKK1 binding agents and combinations of these agents, along with related methods of treatment. Another significant patent involves antibodies that specifically bind beta-like glycoprotein hormone polypeptides and their heterodimers. This patent discloses novel β10 polypeptides and heterodimers, as well as nucleic acid molecules encoding them. It also provides methods for the treatment, diagnosis, amelioration, or prevention of diseases using these polypeptides and their respective binding agents.

Career Highlights

Christopher has worked with prominent companies in the biotechnology sector, including Amgen Inc. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.

Collaborations

Throughout his career, Christopher has collaborated with notable colleagues such as Jin Cao and Dimitry Michael Danilenko. These collaborations have likely enhanced his research and development efforts.

Conclusion

Christopher J R Paszty is a distinguished inventor whose work in biotechnology has led to significant advancements in medical treatments. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.